A novel PRMT5 inhibitor with potent in vitro and in vivo activity in preclinical lung cancer models

被引:15
|
作者
Brehmer, Dirk
Wu, Tongfei
Mannens, Geert
Beke, Lijs
Vinken, Petra
Gaffney, Dana
Sun, Weimei
Pande, Vineet
Thuring, Jan-Willem
Millar, Hillary
Poggesi, Italo
Somers, Ivan
Boeckx, An
Parade, Marc
van Heerde, Erika
Nys, Thomas
Yanovich, Carol
Herkert, Barbara
Verhulst, Tinne
Du Jardin, Marc
Meerpoel, Lieven
Moy, Christopher
Diels, Gaston
Viellevoye, Marcel
Schepens, Wim
Poncelet, Alain
Linders, Joannes T.
Lawson, Edward C.
Edwards, James P.
Chetty, Dushen
Laquerre, Sylvie
Lorenzi, Matthew V.
机构
关键词
D O I
10.1158/1538-7445.AM2017-DDT02-04
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DDT02-04
引用
收藏
页数:2
相关论文
共 50 条
  • [41] JBI-778, a novel brain-penetrant small molecule PRMT5 inhibitor for treatment of cancer
    Sivanandhan, Dhanalakshmi
    Gajendran, Chandru
    Sadhu, Naveen M.
    Mohammed, Zainuddin
    Gosu, Ramachandraiah
    Sher, Divsha
    Mansur, Shahar
    Friedmann-Morvinski, Dinorah
    Rajagopal, Sridharan
    Rastelli, Luca
    CANCER RESEARCH, 2023, 83 (07)
  • [42] Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity
    Kongkai Zhu
    Jingwei Shao
    Hongrui Tao
    Xue Yan
    Cheng Luo
    Hua Zhang
    Wenhu Duan
    Journal of Computer-Aided Molecular Design, 2019, 33 : 775 - 785
  • [43] Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity
    Zhu, Kongkai
    Shao, Jingwei
    Tao, Hongrui
    Yan, Xue
    Luo, Cheng
    Zhang, Hua
    Duan, Wenhu
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2019, 33 (08) : 775 - 785
  • [44] Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer
    Shane O’Brien
    Michael Butticello
    Christine Thompson
    Boris Wilson
    Anastasia Wyce
    Vivek Mahajan
    Ryan Kruger
    Helai Mohammad
    Andy Fedoriw
    BMC Cancer, 23
  • [45] Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer
    O'Brien, Shane
    Butticello, Michael
    Thompson, Christine
    Wilson, Boris
    Wyce, Anastasia
    Mahajan, Vivek
    Kruger, Ryan
    Mohammad, Helai
    Fedoriw, Andy
    BMC CANCER, 2023, 23 (01)
  • [46] A comprehensive investigation of PRMT5 in the prognosis and ion channel features of lung cancer
    Wang, Yan
    Chu, Daifang
    Li, Haichao
    Fan, Jiangjiang
    Zhu, Ximing
    Ma, Yulong
    Gu, Zhongping
    Xie, Nianlin
    Jing, Pengyu
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Establishing the role of PRMT5 in lung cancer tumorigenicity and modulation of expression in smokers
    Ali, Syed N.
    Patel, Meet
    Dieng, Bamby
    Lund, Cody
    Puri, Neelu
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Discovery of SAM competitive, brain-restricted PRMT5 inhibitors with potent antitumor activity
    Tatlock, John
    Billitti, Joseph
    Braganza, John
    Brooun, Alexei
    Deng, Ya-Li
    Hirakawa, Brad
    Jensen-Pergakes, Kristen
    Kumpf, Robert
    Liu, Wei
    Maegley, Karen
    McAlpine, Indrawan
    McTigue, Michele
    Patman, Ryan
    Rui, Eugene
    Scales, Stephanie
    Tran-Dube, Michelle
    Wang, Fen
    Wang, Zhenxiong
    Yamazaki, Shinji
    Zhang, Tao
    Wythes, Martin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [49] Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo
    Ruiying Yang
    Shuhong Dong
    Jinghui Zhang
    Shihao Zhu
    Guoliang Miao
    Baolai Zhang
    Molecular and Cellular Biochemistry, 2023, 478 : 1031 - 1044
  • [50] AZ-PRMT5i-1: A potent MTAP-selective PRMT5 inhibitor with pharmacodynamic and monotherapy anti-tumor activity in MTAP-deleted tumours
    Lynch, James T.
    Moore, Shaun
    Barrantes, Ivan Del Barco
    Bradshaw, Lauren
    Chambers, Chris
    Hong, Ted
    Cooke, Sophie
    Urosevic, Jelena
    Vazquez-Chantada, Mercedes
    Smith, James M.
    Cronin, Anna
    Recolin, Benedicte
    Gill, Sonja
    Critchlow, Susan
    Chan, Ho Man
    Dean, Emma
    CANCER RESEARCH, 2023, 83 (07)